华商医药消费精选混合A(013956)资产负债表
| |
2026-06-30 |
2025-12-31 |
2025-06-30 |
2024-12-31 |
| 资产 |
| 银行存款 |
- |
- |
- |
- |
| 结算备付金 |
961,389.92 |
11,267,713.44 |
3,735,338.69 |
4,937,067.21 |
| 存出保证金 |
346,386.91 |
347,513.60 |
174,569.81 |
147,096.63 |
| 交易性金融资产 |
140,719,045.13 |
245,172,701.46 |
210,445,264.23 |
178,036,494.65 |
| 其中:股票投资 |
140,719,045.13 |
245,172,701.46 |
210,445,264.23 |
178,036,494.65 |
| 债券投资 |
- |
- |
- |
- |
| 资产支持证券投资 |
- |
- |
- |
- |
| 衍生金融资产 |
- |
- |
- |
- |
| 买入返售金融资产 |
- |
- |
- |
- |
| 应收证券清算款 |
2,553,010.25 |
8,795,256.16 |
193,288.03 |
11,190,296.53 |
| 应收利息 |
- |
- |
- |
- |
| 应收股利 |
62,514.15 |
- |
270,190.88 |
- |
| 应收申购款 |
332,164.40 |
11,078.60 |
30,314.10 |
12,269.25 |
| 其他资产 |
- |
- |
- |
- |
| 资产总计 |
161,383,459.08 |
301,317,307.44 |
236,476,826.76 |
226,604,897.60 |
| 负 债 |
| 短期借款 |
- |
- |
- |
- |
| 交易性金融负债 |
- |
- |
- |
- |
| 衍生金融负债 |
- |
- |
- |
- |
| 卖出回购金融资产款 |
- |
- |
- |
- |
| 应付证券清算款 |
145,741.56 |
14,630,640.86 |
1,433,054.25 |
10,809,317.76 |
| 应付赎回款 |
1,261,205.43 |
938,498.48 |
138,454.89 |
280,714.36 |
| 应付管理人报酬 |
147,268.21 |
306,403.03 |
233,117.67 |
226,945.59 |
| 应付托管费 |
24,544.69 |
51,067.16 |
38,852.92 |
37,824.27 |
| 应付销售服务费 |
4,531.85 |
35,020.94 |
5,362.90 |
4,998.39 |
| 应付交易费用 |
- |
- |
- |
- |
| 应交税费 |
- |
- |
- |
- |
| 应付利息 |
- |
- |
- |
- |
| 应付利润 |
- |
- |
- |
- |
| 其他负债 |
526,176.59 |
571,004.23 |
678,387.99 |
453,316.99 |
| 负债合计 |
2,109,468.33 |
16,532,634.70 |
2,527,230.62 |
11,813,117.36 |
| 所有者权益 |
| 实收基金 |
243,044,274.85 |
396,220,361.34 |
318,598,466.64 |
335,682,125.40 |
| 未分配利润 |
-83,770,284.10 |
-111,435,688.60 |
-84,648,870.50 |
-120,890,345.16 |
| 所有者权益合计 |
159,273,990.75 |
284,784,672.74 |
233,949,596.14 |
214,791,780.24 |
| 负债及所有者权益总计 |
161,383,459.08 |
301,317,307.44 |
236,476,826.76 |
226,604,897.60 |
欢迎访问证券之星!请点此与我们联系 版权所有: Copyright © 1996-年